Adeptus Health Inc. (NYSE:ADPT) Files An 8-K Bankruptcy or ReceivershipItem 1.03 Bankruptcy or Receivership
As previously reported by Adeptus Health Inc. (the “Company”), on April19, 2017, the Company and its subsidiaries (such subsidiaries, together with the Company, the “Debtors”) filed voluntary petitions (collectively, the “Petitions” and, the cases thereby, the “Bankruptcy Cases”) with the United States Bankruptcy Court for the Northern District of Texas, Dallas Division (the “Bankruptcy Court”) for reorganization relief under chapter 11 of title 11 of the United States Code. The cases were consolidated for administrative purposes only under Case No.17-31432.
On September29, 2017, the Bankruptcy Court entered an order (the “Confirmation Order”), attached hereto as Exhibit99.1, confirming the Debtors’ Third Amended Joint Plan of Reorganization to Chapter 11 of the Bankruptcy Code (the “Plan”), attached hereto as Exhibit99.2. The Plan became effective on October2, 2017 (the “Effective Date”).
Summary of the Material Features of the Plan
The following is a summary of the material features of the Plan. This summary highlights only certain substantive provisions of the Plan and is not intended to be a complete description of the Plan. This summary is qualified in its entirety by reference to the full text of the Confirmation Order and the Plan, which are attached hereto as Exhibit99.1 and Exhibit99.2 and incorporated by reference herein.
The Plan implements extensive negotiations that have occurred between the Debtors and various parties, including Deerfield Management Company, L.P. and certain funds advised by Deerfield Mgmt, L.P. (collectively, the “Deerfield Parties”).
to and subject to the terms of the Plan, on the Effective Date of the Plan:
· Holders of ClassA common stock shall have the option to receive their pro rata share of the Deerfield Parties’ recovery on account of the Deerfield Deficiency Claims in exchange for releasing the “Released Parties” (as defined in the Plan). Holders of ClassA common stock will receive notice of the ability to opt out of such releases (and not receive any potential distributions under the Deerfield Deficiency Claims). Any holder who wishes to opt out of such releases must return such notice to the instructions set forth therein. If a holder wishes to grant such